What is needed to familiarize oncologists with biosimilar medicines?

Biosimilar medicines have delivered 18BN€ total savings for… 15 December 2021 Open
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
Biosimilar medicines: competition, sustainability and early*… 30 October 2019 Medicines for Europe welcomes 5th European Commission Stakeholder event on…
A new medicines trade and health security agenda for the… 19 February 2021 In response to the European Commission Trade Communication published on…